Ekonomicke aspekty lecby benigni hyperplazie prostaty

Translated title of the contribution: Economic aspects of treatment of benign hyperplasia of the prostate

D. Pacik, H. Logan Holtgrewe

Research output: Contribution to journalArticle


BPH is a relatively frequent disease and the costs associated with its treatment contribute in a major way to the costs of treatment of urological patients. Alternative medicamentous and less invasive therapeutic methods led to a decline in the rising number of prostatectomies but did not lead to the assumed decline of costs, on the contrary. The question remains how to rationalise to a maximum extent these costs which should be met from public resources, in particular in this disease which usually does not threaten the patient's health nor life. Allocation of constant resources from the gross national product to health services is an important problem also in conjunction with the diagnosis and treatment of BPH.

Original languageCzech
Pages (from-to)178-181
Number of pages4
JournalPrakticky Lekar
Issue number3
Publication statusPublished - 1999
Externally publishedYes



  • Benign hyperplasia of the prostate
  • Economic aspects
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pacik, D., & Logan Holtgrewe, H. (1999). Ekonomicke aspekty lecby benigni hyperplazie prostaty. Prakticky Lekar, 79(3), 178-181.